Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

In the last decades, the prognosis of metastatic renal cell carcinoma (mRCC) has remarkably improved following the advent of the “targeted therapy” era. The expanding knowledge on the prominent role played by angiogenesis in RCC pathogenesis has led to approval of multiple anti-angiogenic agents suc...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Aniello, Carmine, Berretta, Massimiliano, Cavaliere, Carla, Rossetti, Sabrina, Facchini, Bianca Arianna, Iovane, Gelsomina, Mollo, Giovanna, Capasso, Mariagrazia, Pepa, Chiara Della, Pesce, Laura, D'Errico, Davide, Buonerba, Carlo, Di Lorenzo, Giuseppe, Pisconti, Salvatore, De Vita, Ferdinando, Facchini, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917607/
https://www.ncbi.nlm.nih.gov/pubmed/31921657
http://dx.doi.org/10.3389/fonc.2019.01400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917607/
https://www.ncbi.nlm.nih.gov/pubmed/31921657
http://dx.doi.org/10.3389/fonc.2019.01400

Ejemplares similares